Bridging Specialties™: Timely Diagnosis of ILD

3.50 CME

3.50 CNE

210 MINS

$0 FEE

Overview

Bridging Specialties™: Timely Diagnosis of ILD empowers healthcare professionals to provide timely diagnosis for patients with interstitial lung disease (ILD). By providing practical information and tools to help healthcare professionals recognize the signs and symptoms of ILD and understand the diagnostic process, patients can be diagnosed earlier and experience better disease management and quality of life.

This program consists of two learning activities:
Bridging Specialties™: Early Detection for ILD
Enhance your recognition and awareness of ILDs to shorten the time to diagnosis for your patients.

Bridging Specialties™: ILD Decision-Making Tool
Conduct a simulated visit with patients and choose which clinical actions to take based on presentation.

Visit the CHEST website to access the Bridging Specialties™: ILD Clinician Toolkit containing additional resources focused on the steps to take when a patient displays signs of ILD. From an ILD-specific patient questionnaire, to a decision-making tool that walks you through patient scenarios, and much more, this toolkit can help you reach an earlier diagnosis and start treatment for your patients more quickly—since time lost is lung lost.

Provider Statement

This continuing medical education activity is provided by The American College of Chest Physicians.

CHEST

Support Statement

Bridging Specialties™: Timely Diagnosis for ILD is provided by the American College of Chest Physicians in partnership with Three Lakes Foundation.

Target Audience

The intended audience for this activity is pulmonologists, rheumatologists, radiologists, and other healthcare professionals involved in the diagnosis, and management, of patients with interstitial lung disease (ILD).

Learning Objectives

Upon completion of this activity, participants should be better able to:

Identify the classic symptoms of ILDs.
Describe how patient history, ILD-specific questionnaires, and additional workups impact early detection in adults with suspected ILD.
Recognize how early suspicion of ILD and detection benefits patients receiving treatment options earlier through partnerships with an ILD specialist.

Faculty

Jessica Glennie, APRN, MSN
Nurse Practitioner, Interstitial Lung Disease Clinic, Cleveland Clinic

William Lago, MD
Family Medicine Physician, Wooster Family Health Center, Cleveland Clinic Foundation

Anoop M. Nambiar, MD, MS, FCCP
Founding Director, Center for Interstitial Lung Diseases, University of Texas Health Science Center at San Antonio

Mary Beth Scholand, MD, FCCP
Director, Interstitial Lung Disease Clinic, University of Utah, Salt Lake City

Accreditation

The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physician Credit

The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American College of Chest Physicians designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

Provider approved by the California Board of Registered Nursing, Provider Number 16433, for 3.5 contact hours.

Nurse Practitioners

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

Physician Assistants

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 3.5 Category 1 credits for completing this activity.

Maintenance of Licensure

Successful completion of this CME activity enables the participant to earn up to 3.5 MOC Part 2 Medical Knowledge points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Upon successful completion of this course, CHEST will submit your completion data to ABIM via ACCME's Program and Activity Reporting System (PARS) for MOC points. Please allow 3-5 business days after claiming for points to be reflected on your ABIM record.

The participation threshold or passing standard for this activity is learner completion of the module, “Early Detection of ILD”, the module, “Decision Making Tool”, and completion of the activity evaluation documenting expected changes in practice.

How to Participate in This Activity and Obtain CE Credit

To complete the Education Activity Evaluation for CHEST Curriculum Pathway for Asthma: Treatment Highlights, claim CME/CE credits, and download CME/CE certificates and certificates of attendance (COA), please see the instructions below. You must complete your evaluation and download your certificate prior to the product expiration date.

Sign in and navigate to your "My Learning" account at education.chestnet.org.
Find the course or event in your list and complete all required post-course work.
Claim credits when prompted.

Your certificate and transcript can be viewed at any time under Claimed Activities on the Manage CME page. If you need help, contact the CHEST Help Team at HelpTeam@chestnet.org. For faster assistance, outline the specific problem you are having, and provide your CHEST ID and contact information.

Disclosures

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

CHEST remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any relevant financial relationships that create a conflict of interest. It is not the intent of CHEST to disqualify anyone from participating in this educational activity, but to resolve any conflicts of interest that may arise from financial relationships with commercial interests. All conflicts of interest are reviewed by the educational activity course director/chair, the Education Committee, and/or the Professional Standards Committee to ensure that such situations are properly evaluated and, if necessary, resolved. CHEST educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all CHEST CME activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relevant financial relationships will be made available on-site during all educational activities.

The following faculty members of this activity have disclosed to CHEST that they have a relevant financial relationship with a commercial interest as it relates to the activity:

Jessica Glennie, APRN, MSN—Boehringer Ingelheim, United Therapeutics Corporation
Anoop M. Nambiar, MD, MS, FCCP—Boehringer Ingelheim; Genentech, a member of the Roche Group; Veracyte
Mary Beth Scholand, MD, FCCP—Boehringer Ingelheim; Genentech, a member of the Roche Group; United Therapeutics Corporation; Veracyte

The following faculty members of this activity have indicated to CHEST that they have no relevant financial relationships with any commercial interests:

William Lago, MD—Nothing to Disclose

Notification Bell Alerts